{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF01353",
      "entity_text" : "GFP",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:44263853",
      "entity_text" : "TAC",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "TAC induced significant cardiac hypertrophy, as characterized by an increased left ventricular wall thickness [left ventricular anterior wall thickness at end diastole (LVAWd)], decreased left ventricular cavity dimension [left ventricular internal dimension at end diastole (LVIDd)], increased heart-to-body weight ratio and an expanded cross-sectional area of cardiomyocytes in the GFP treated mice.",
  "reading_complete" : "2020-08-02T16:04:02Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T16:03:00Z",
  "trigger" : "increased",
  "evidence" : [ "TAC induced significant cardiac hypertrophy, as characterized by an increased left ventricular wall thickness [left ventricular anterior wall thickness at end diastole (LVAWd)], decreased left ventricular cavity dimension [left ventricular internal dimension at end diastole (LVIDd)], increased heart-to-body weight ratio and an expanded cross-sectional area of cardiomyocytes in the GFP" ],
  "pmc_id" : "4356433",
  "score" : 0
}